NDAQ stock news
This page provides real-time market news, earnings updates, and company announcements related to Nasdaq, Inc. (NDAQ).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-03 08:25 EST
Uni-Fuels Accelerates Global Growth with Nationwide Bunkering in Thailand
Finviz2026-03-03 13:01:04
Upexi to Participate in Upcoming March Investor Conferences
Finviz2026-03-03 13:03:52
Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer
Finviz2026-03-03 13:03:53
Logistics solutions provider Hub Group Inc recently issued a statement, expecting to formally acknowledge that the company failed to maintain effective disclosure controls and internal control over financial reporting for the fiscal year ending December 31, 2025.
老虎证券2026-03-03 13:07:04
Certara Simcyp Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
Finviz2026-03-03 13:03:53
Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-03 13:03:50
Arcutis Begins Enrolling Phase 1a/1b Study Evaluating ARQ-234, a CD200R Agonist, in Healthy Volunteers and Adults With Atopic Dermatitis
Finviz2026-03-03 13:03:51
Infosys Partners With Intel To Accelerate Secure Enterprise AI At Scale
Finviz2026-03-03 13:01:03
Nanox Signs Distribution Agreement with Imperial Imaging Technology to Expand Nanox.ARC Access Across U.S. Southeast
Finviz2026-03-03 13:03:52
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
Finviz2026-03-03 13:03:51
Nanox Signs Distribution Agreement with Imperial Imaging Technology to Expand Nanox.ARC Access Across U.S. Southeast
Finviz2026-03-03 13:03:52
VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales
Finviz2026-03-03 13:09:09
Rein Therapeutics Doses First Patient in Phase 2 Trial of LTI-03 for Idiopathic Pulmonary Fibrosis
Finviz2026-03-03 13:03:53
Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference
Finviz2026-03-03 13:03:53
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
Finviz2026-03-03 13:03:53
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-03 13:03:52
FBS Global Regains Full Nasdaq Compliance; Minimum Bid Price Matter Resolved
Finviz2026-03-03 13:03:52
Enphase Energy and Capital Good Fund to Expand IQ Microinverter Deployments for Small Commercial and Residential Projects in the United States
Finviz2026-03-03 13:03:53
Antelope Enterprise Holdings Limited Announce Reverse Split Record Date
Finviz2026-03-03 13:03:51
KUSTOM ENTERTAINMENT'S DIGITAL ALLY BRAND SECURES MULTI-YEAR BODY CAMERA SUBSCRIPTION WITH PREMIER KANSAS CITY BASED HEALTH SYSTEM
Finviz2026-03-03 13:03:51
BioCardia Late Breaking Echocardiography Clinical Results from CardiAMP HF Trial Presented at Technology and Heart Failure Therapeutics (THT)
Finviz2026-03-03 13:03:52
Kyverna Therapeutics to Participate in Upcoming March Investor Conferences
Finviz2026-03-03 13:03:52
Kratos Receives $7 Million Order for Counter-UAS Systems
Finviz2026-03-03 13:03:53
Aptera Motors Completes First Vehicle off Validation Assembly Line
Finviz2026-03-03 13:03:50
Certara Simcyp Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
Finviz2026-03-03 13:03:53
Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-03 13:03:50
Arcutis Begins Enrolling Phase 1a/1b Study Evaluating ARQ-234, a CD200R Agonist, in Healthy Volunteers and Adults With Atopic Dermatitis
Finviz2026-03-03 13:03:51
Infosys Partners With Intel To Accelerate Secure Enterprise AI At Scale
Finviz2026-03-03 13:01:03
Nanox Signs Distribution Agreement with Imperial Imaging Technology to Expand Nanox.ARC Access Across U.S. Southeast
Finviz2026-03-03 13:03:52
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
Finviz2026-03-03 13:03:51
Nanox Signs Distribution Agreement with Imperial Imaging Technology to Expand Nanox.ARC Access Across U.S. Southeast
Finviz2026-03-03 13:03:52
VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales
Finviz2026-03-03 13:09:09
Rein Therapeutics Doses First Patient in Phase 2 Trial of LTI-03 for Idiopathic Pulmonary Fibrosis
Finviz2026-03-03 13:03:53
Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference
Finviz2026-03-03 13:03:53
Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT
Finviz2026-03-03 13:03:53
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-03 13:03:52
FBS Global Regains Full Nasdaq Compliance; Minimum Bid Price Matter Resolved
Finviz2026-03-03 13:03:52
Enphase Energy and Capital Good Fund to Expand IQ Microinverter Deployments for Small Commercial and Residential Projects in the United States
Finviz2026-03-03 13:03:53
Antelope Enterprise Holdings Limited Announce Reverse Split Record Date
Finviz2026-03-03 13:03:51
KUSTOM ENTERTAINMENT'S DIGITAL ALLY BRAND SECURES MULTI-YEAR BODY CAMERA SUBSCRIPTION WITH PREMIER KANSAS CITY BASED HEALTH SYSTEM
Finviz2026-03-03 13:03:51
BioCardia Late Breaking Echocardiography Clinical Results from CardiAMP HF Trial Presented at Technology and Heart Failure Therapeutics (THT)
Finviz2026-03-03 13:03:52
Kyverna Therapeutics to Participate in Upcoming March Investor Conferences
Finviz2026-03-03 13:03:52
Kratos Receives $7 Million Order for Counter-UAS Systems
Finviz2026-03-03 13:03:53
Aptera Motors Completes First Vehicle off Validation Assembly Line
Finviz2026-03-03 13:03:50
NDAQ stock chart
NDAQ stock detailsNDAQ stock price change
On the last trading day, NDAQ stock closed at 87.58 USD, with a price change of -1.14% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more